Home The Word Brain	My Amedeo FAQ Privacy About
	2049 Chinese The 20K Word Road to Mandarin Proficiency By B. S. Kamps et al.

Obstructive Lung Diseases

Free Subscription Articles published in Rev Mal Respir Retrieve available abstracts of 58 articles: HTML format

Single Articles

March 2024
1. JUSTEAU G, Toigo M, Castro de Freitas T, Ribeiro Baptista B, et al
   [Pulmonary lipofibroblasts in adults and alveolar regeneration in emphysema].
   Rev Mal Respir. 2024 Mar 8:S0761-8425(24)00145-1. doi: 10.1016/j.rmr.2024.
   PubMed     Abstract available
   
   
   
2. AHMED E, Assou S, Foisset F, Bourdais C, et al
   [Modeling T2 high severe asthma using human induced pluripotent stem cells (hiPSC)].
   Rev Mal Respir. 2024 Mar 8:S0761-8425(24)00142-6. doi: 10.1016/j.rmr.2024.
   PubMed     Abstract available
   
   
   February 2024
3. GADDOUR A, Chatti S, Chouchene A, Kacem I, et al
   [An epidemiological and evolutionary profile of occupational asthma of Tunisian workers].
   Rev Mal Respir. 2024 Feb 29:S0761-8425(24)00116.
   PubMed     Abstract available
   
   
   
4. REGARD L, Deslee G, Zysman M, Le Rouzic O, et al
   [Position paper of the French Language Society of Respiratory Diseases regarding the GOLD 2023 classification: Capital E].
   Rev Mal Respir. 2024;41:97-101.
   PubMed    
   
   
   
5. GUECAMBURU M, Zysman M
   [Biologic agents in COPD management].
   Rev Mal Respir. 2024;41:127-138.
   PubMed     Abstract available
   
   
   January 2024
6. SOUMAGNE T, Chenivesse C, Didier A, Giovannini-Chami L, et al
   [Written action plans for asthma control: How are they used by pulmonologists in France?].
   Rev Mal Respir. 2024 Jan 15:S0761-8425(24)00001.
   PubMed     Abstract available
   
   
   November 2023
7. AKDIME F, Habib S, Regard L, Terrier B, et al
   [Anti-IL-5 in severe asthma associated with eosinophilic granulomatosis with polyangiitis. Real-life study].
   Rev Mal Respir. 2023 Nov 1:S0761-8425(23)00262-0. doi: 10.1016/j.rmr.2023.
   PubMed     Abstract available
   
   
   
8. UNDERNER M, Perriot J, Peiffer G, Brousse G, et al
   [Bronchial diseases and heroin use. A systematic review].
   Rev Mal Respir. 2023;40.
   PubMed     Abstract available
   
   
   
9. EGENOD T, Deslee G, Degano B
   [Bronchoscopic COPD treatments].
   Rev Mal Respir. 2023;40.
   PubMed     Abstract available
   
   
   September 2023
10. AMAT F
    [Biologics in severe childhood asthma].
    Rev Mal Respir. 2023 Sep 23:S0761-8425(23)00236.
    PubMed     Abstract available
    
    
    
11. MOULINIE J, Hayot M, Gouzi F
    [The FEV(1)/VC ratio to define bronchial obstruction: Should we use a fixed ratio or the lower limit of normal?].
    Rev Mal Respir. 2023;40:564-571.
    PubMed     Abstract available
    
    
    August 2023
12. BELLOUMI N, Bougacha M, Habouria C, Bachouche I, et al
    [Level of knowledge on occupational asthma and asthmagens: Assessment among healthcare workers by a validated questionnaire].
    Rev Mal Respir. 2023 Aug 31:S0761-8425(23)00199.
    PubMed     Abstract available
    
    
    June 2023
13. MARCOT C, Migueres N, Ott M, Khayath N, et al
    [Allergenic and chemical pollutants of indoor environments and asthma: Characterization, assessment and expulsion].
    Rev Mal Respir. 2023 Jun 28:S0761-8425(23)00174.
    PubMed     Abstract available
    
    
    
14. PEIFFER G, Perriot J, Underner M, Rouquet RM, et al
    [Smoking cessation treatment for smokers with COPD: The importance of therapeutic education].
    Rev Mal Respir. 2023;40:520-530.
    PubMed     Abstract available
    
    
    April 2023
15. OUEDRAOGO AR, Boncoungou K, Ouedraogo JCRP, Ouedraogo GA, et al
    [Availability and affordability of diagnosis and treatment for asthma and COPD in Ouagadougou, Burkina Faso].
    Rev Mal Respir. 2023 Apr 14:S0761-8425(23)00135.
    PubMed     Abstract available
    
    
    March 2023
16. CHESSERON S, Saidi A, Lecaille F, Lalmanach G, et al
    [Alteration of pulmonary epithelial permeability by cathepsin S in chronic obstructive pulmonary disease].
    Rev Mal Respir. 2023;40:250-253.
    PubMed     Abstract available
    
    
    
17. FOISSET F, Lehalle C, Nasri A, Bourdais C, et al
    [Production of innervated bronchial epithelium from a blood sample].
    Rev Mal Respir. 2023;40:247-249.
    PubMed     Abstract available
    
    
    
18. BRUGIERE O, Bergeron A, Le Pavec J
    [Lung transplantation for chronic graft-versus-host disease after hematopoietic stem cell transplantation].
    Rev Mal Respir. 2023;40 Suppl 1:e69-e72.
    PubMed    
    
    
    
19. BUNEL V, Brioude G, Deslee G, Stelianides S, et al
    [Selection of candidates for lung transplantation for chronic obstructive pulmonary disease].
    Rev Mal Respir. 2023;40 Suppl 1:e22-e32.
    PubMed    
    
    
    February 2023
20. MARCOZZI N, Tiotiu A
    [The impact of specialized management on allergic asthma outcomes].
    Rev Mal Respir. 2023 Feb 3:S0761-8425(23)00034-7. doi: 10.1016/j.rmr.2023.
    PubMed     Abstract available
    
    
    January 2023
21. RENAUD-PICARD B, Tissot A, Burgel PR, Grenet D, et al
    [Lung transplantation for cystic fibrosis and other bronchiectasies].
    Rev Mal Respir. 2023 Jan 5:S0761-8425(22)00468-5. doi: 10.1016/j.rmr.2022.
    PubMed    
    
    
    December 2022
22. FIEUTELOT G, Valentin S, Ribeiro Baptista B, Chaouat A, et al
    [Nurse practitioners as key actors in pulmonary rehabilitation for chronic obstructive pulmonary disease].
    Rev Mal Respir. 2022;39:822-831.
    PubMed     Abstract available
    
    
    October 2022
23. BEN AMEUR S, Elasmar K, Jdidi J, Belhadj R, et al
    [General practitioners' management of childhood asthma in Sfax, Tunisia].
    Rev Mal Respir. 2022 Oct 19. pii: S0761-8425(22)00313.
    PubMed     Abstract available
    
    
    
24. PRADERE P, Ruppert AM, Peiffer G, Perriot J, et al
    [Inhaled marijuana and the lung, a toxic cocktail?]
    Rev Mal Respir. 2022;39:708-718.
    PubMed     Abstract available
    
    
    
25. GINDRE D, Surpas P, Garcia-Tejero MT, Decullier E, et al
    [Is helium beneficial in a pulmonary rehabilitation program for severe COPD?]
    Rev Mal Respir. 2022;39:676-684.
    PubMed     Abstract available
    
    
    
26. GUECAMBURU M, Zysman M
    [COPD and eosinophils].
    Rev Mal Respir. 2022;39:685-697.
    PubMed     Abstract available
    
    
    
27. GHILAIN A, Marchand E
    [The forced oscillation technique in the functional evaluation of COPD dyspnea].
    Rev Mal Respir. 2022;39:659-668.
    PubMed     Abstract available
    
    
    
28. MORNEX JF
    [Alpha 1-antitrypsin deficiency].
    Rev Mal Respir. 2022;39:698-707.
    PubMed     Abstract available
    
    
    September 2022
29. SESE L, Mahay G, Barnig C, Guibert N, et al
    [Markers of severity and predictors of response to treatment in severe asthma].
    Rev Mal Respir. 2022 Sep 14. pii: S0761-8425(22)00285.
    PubMed     Abstract available
    
    
    
30. CARRETTE A, Mercier V, Lelubre C, Peche R, et al
    [Benralizumab in cases of eosinophilic granulomatosis with polyangiitis].
    Rev Mal Respir. 2022;39:621-625.
    PubMed     Abstract available
    
    
    June 2022
31. BALLAND MH, Sizaret O, Fraih E
    [Hindrances to the prescription of respiratory rehabilitation in general medicine].
    Rev Mal Respir. 2022;39:516-522.
    PubMed     Abstract available
    
    
    May 2022
32. JEBRAK G, Houdouin V, Terrioux P, Lambert N, et al
    [Therapeutic adherence among asthma patients: Variations according to age groups. How can it be improved? The potential contributions of new technologies].
    Rev Mal Respir. 2022 May 18. pii: S0761-8425(22)00101.
    PubMed     Abstract available
    
    
    
33. DESLEE G, Zysman M, Gonzalez-Bermejo J, Roche N, et al
    [First COPD Biennale of the French-language Respiratory Society 2021: At last!]
    Rev Mal Respir. 2022;39:411-412.
    PubMed    
    
    
    
34. ANCEL J, Guecamburu M, Marques Da Silva V, Schilfarth P, et al
    [Take-home messages from the COPD 2021 biennial of the French Society of Respiratory Diseases. Understanding to so as to better innovate].
    Rev Mal Respir. 2022;39:427-441.
    PubMed     Abstract available
    
    
    April 2022
35. UNDERNER M, Peiffer G, Perriot J, De Chazeron I, et al
    [Asthma and suicidal behavior in adolescents: a literature review].
    Rev Mal Respir. 2022 Apr 19. pii: S0761-8425(22)00111.
    PubMed     Abstract available
    
    
    
36. MEDRINAL C, Bonnevie T
    [Physiotherapy during and after acute exacerbation of COPD].
    Rev Mal Respir. 2022;39:386-397.
    PubMed     Abstract available
    
    
    March 2022
37. GAUTHIER R, Vassail J, Croutaz JP, Raspaud C, et al
    [Active mind-body movement therapies and pulmonary rehabilitation for people with COPD].
    Rev Mal Respir. 2022;39:258-269.
    PubMed     Abstract available
    
    
    February 2022
38. DRUMMOND D
    [Digital tools for remote monitoring of asthma patients: Gadgets or revolution?]
    Rev Mal Respir. 2022 Feb 23. pii: S0761-8425(22)00102.
    PubMed     Abstract available
    
    
    
39. HASSOUN D, Loirand G, Sauzeau V
    [A new pathophysiological element in severe asthma: GTPase Rac].
    Rev Mal Respir. 2022 Feb 16. pii: S0761-8425(22)00030.
    PubMed     Abstract available
    
    
    
40. DESCHILDRE A, Abou-Taam R, Drummond D, Giovannini-Chami L, et al
    [Update of the 2021 Recommendations for the management of and follow-up of adolescent asthmatic patients (over 12 years) under the guidance of the French Society of Pulmonology and the Paediatric Society of Pulmonology and Allergology. Long version].
    Rev Mal Respir. 2022 Feb 8. pii: S0761-8425(21)00333.
    PubMed    
    
    
    
41. DESCHILDRE A, Abou Taam R, Drummond D, Giovannini-Chami L, et al
    [Update guidelines for management of asthmatic patients (from 12 years and older). Short version].
    Rev Mal Respir. 2022 Feb 8. pii: S0761-8425(21)00343.
    PubMed    
    
    
    
42. EYRAUD E, Berger P, Contin-Bordes C, Dupin I, et al
    [CD8(+) T cells and fibrocytes: dangerous interplay in the distal bronchi of patients with chronic obstructive pulmonary disease?]
    Rev Mal Respir. 2022;39:90-94.
    PubMed     Abstract available
    
    
    
43. CHOTTIN C, Marquant Q, Saint-Criq V, Thomas M, et al
    [Pulmonary mucosa during the perinatal period: Can understanding of the lung help to combat the infant's sensitivity to bronchiolitis?]
    Rev Mal Respir. 2022;39:104-107.
    PubMed     Abstract available
    
    
    
44. HAYOT M, Saey D, Costes F, Bughin F, et al
    [Respiratory telerehabilitation in cases of COPD].
    Rev Mal Respir. 2022;39:140-151.
    PubMed     Abstract available
    
    
    January 2022
45. RAHERISON-SEMJEN C, Guilleminault L, Billiart I, Chenivesse C, et al
    [Erratum to "Updated guidelines for management of asthmatic patients (from 12 years and older). Short version" [Rev. Mal. Respir. 38 (2021) e1-e13]].
    Rev Mal Respir. 2022 Jan 25. pii: S0761-8425(22)00002.
    PubMed    
    
    
    
46. RAHERISON-SEMJEN C, Guilleminault L, Billiart I, Chenivesse C, et al
    [Erratum to "Update of the 2021 recommendations for the management and follow-up of adult asthmatic patients under the guidance of the French Society of Pulmonology and the Paediatric Society of Pulmonology and Allergology. Long version" [Rev. Mal. Re
    Rev Mal Respir. 2022 Jan 25. pii: S0761-8425(22)00001.
    PubMed    
    
    
    
47. STORME N, Toublanc B, Mejdoub F, Baud M, et al
    [Tracheal lipoma: An exceptional cause of tracheal tumors].
    Rev Mal Respir. 2022;39:58-61.
    PubMed     Abstract available
    
    
    December 2021
48. GHRENASSIA G, Grassion L, Molimard M, Sanchez-Pena P, et al
    [Introduction of an anticholinesterase drug in the context of myasthenia, in a severe asthmatic patient].
    Rev Mal Respir. 2021 Dec 2. pii: S0761-8425(21)00400.
    PubMed     Abstract available
    
    
    
49. RAHERISON-SEMJEN C
    [The 2021 asthma management guidelines have finally arrived!]
    Rev Mal Respir. 2021;38:951-952.
    PubMed    
    
    
    
50. CACHAU F, Masson A, Di Patrizio P
    [Identifying the barriers to pulmonary rehabilitation for patients with COPD].
    Rev Mal Respir. 2021;38:953-961.
    PubMed     Abstract available
    
    
    
51. CHEHERE B, Pernot J, Costes F
    [Physical activity and pulmonary rehabilitation].
    Rev Mal Respir. 2021;38:993-1004.
    PubMed     Abstract available
    
    
    
52. PREFAUT C, Costes F
    [Pulmonary rehabilitation, a historical perspective from Hippocrates to tele-rehabilitation].
    Rev Mal Respir. 2021;38:1005-1012.
    PubMed     Abstract available
    
    
    November 2021
53. RAHERISON-SEMJEN C, Guilleminault L, Billiart I, Chenivesse C, et al
    [Updated guidelines for management of asthmatic patients (from 12 years and older). Short version].
    Rev Mal Respir. 2021 Nov 25. pii: S0761-8425(21)00334.
    PubMed    
    
    
    
54. RAHERISON-SEMJEN C, Guilleminault L, Billiart I, Chenivesse C, et al
    [Update of the 2021 recommendations for the management and follow-up of adult asthmatic patients under the guidance of the French Society of Pulmonology and the Paediatric Society of Pulmonology and Allergology. Long version].
    Rev Mal Respir. 2021 Nov 16. pii: S0761-8425(21)00332.
    PubMed    
    
    
    
55. THEBAULT JL, Pecqueur R, Teixeira AP
    [Assessment of general practitioners' knowledge of inhalers].
    Rev Mal Respir. 2021;38:873-881.
    PubMed     Abstract available
    
    
    October 2021
56. GAUTIER C, Lecam MT, Basses S, Pairon JC, et al
    [A definition of work-related asthma and its social and occupational consequences in adults and teenagers].
    Rev Mal Respir. 2021 Oct 25. pii: S0761-8425(21)00367.
    PubMed     Abstract available
    
    
    
57. MAURER C, Raherison-Semjen C, Lemaire B, Didi T, et al
    [Severe adult asthma and treatment adherence: Results of the FASE-CPHG study].
    Rev Mal Respir. 2021 Oct 11. pii: S0761-8425(21)00364.
    PubMed     Abstract available
    
    
    May 2021
58. ZYSMAN M, Ribeiro Baptista B, Soumagne T, Marques da Silva V, et al
    [Pharmacological treatment optimisation in patients with stale COPD. Position of the French-language Respiratory Society. 2021 Update].
    Rev Mal Respir. 2021;38:539-561.
    PubMed    
    
    

Thank you for your interest in scientific medicine.

AMEDEO Obstructive Lung Diseases is free of charge.